Experts Warn Against Faricimab Rechallenge Post-Inflammation

Faricimab should be readministered with caution in patients who develop mild intraocular inflammation with a previous dose of the biologic agent, researchers warned.
Medscape Medical News

source https://www.medscape.com/viewarticle/experts-warn-against-faricimab-rechallenge-post-inflammation-2025a100021x?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?